Paclitaxel-Based Chemotherapy in Carcinoma of the Fallopian Tube

Author： Gemignani M.L.   Hensley M.L.   Cohen R.   Venkatraman E.   Saigo P.E.   Barakat R.R.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.80, Iss.1, 2001-01, pp. : 16-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiation Myelopathy after Chemotherapy and Radiation Therapy for Fallopian Tube Carcinoma

By Higgins R.V.   Myers V.T.   Hall J.B.  

Gynecologic Oncology, Vol. 64, Iss. 2, 1997-02 ,pp. : 285-287

Elsevier

Access to resources Recommend Favorite

Paclitaxel-based chemotherapy for patients with refractory or relapsed nonseminomatous germ cell tumors

By Amato R.J.   Prow D.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 4, 2000-07 ,pp. : 134-138

Elsevier

Access to resources Recommend Favorite

Treatment and Survival for Women with Fallopian Tube Carcinoma: A Population-Based Study

By Kosary C.   Trimble E.L.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 190-191

Academic Press

Access to resources Recommend Favorite

Metachronous Carcinoma of the Vulva and Fallopian Tube

By Ichikawa Y.   Tsunoda H.   Nishide K.   Nishida M.   Kubo T.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 206-209

Elsevier

Access to resources Recommend Favorite

Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum

By Markman M.   Zanotti K.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 573-576

Elsevier

Access to resources Recommend Favorite